
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Omrix Biosurgery Israel specializes in the development and manufacture of life-saving products based on human plasma. As a Johnson & Johnson company, we care for the world and are committed to helping people with our innovative solutions. Omrixs products are based on a unique patented technology and are sold throughout the world. Using advanced biotechnological and human-plasma-based products, our solutions help control bleeding during surgery and people with immune deficiencies. Founded in 1995 by Mr. Robert Taub, Omrix went public on the US Stock Exchange in 2006 under the name OMRI. Two years later, Omrix was acquired by American pharmaceutical...
Biopharmaceutical,life-saving products derived from human plasma,diversity and inclusion,and innovation
Omrix biosurgery israel operates in the Biotechnology research industry.
Omrix biosurgery israel's revenue is 11m - 100m
Omrix biosurgery israel has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.